There have been initiatives to create a European audit project. This paper addresses the issue of differences in data collected by different registries.
Patients with rectal cancer treated in 2008 and recorded in quality registries from Belgium, Germany/Poland, Spain and Sweden were analysed. The comparison included number of patients, gender, age, ASA-classification, preoperative diagnostic and staging procedures, neoadjuvant therapy, surgical treatment and quality of surgery, postoperative complications, and adjuvant treatment.
The Belgian database consisted of 622 patients, Germany/Poland 3,393, Spain 1,641 and Sweden 1,826. The percentage of patients in ASA-stages was highly variable.MRI-use was the highest in Spain and Sweden and very low in Germany/Poland. The percentage of cT4 stage tumours in Sweden was much higher than in all other countries. Sweden recorded the highest percentage of primary metastatic disease (20.3%), Belgium the lowest (10.2%). Neoadjuvant therapy in different protocols was administered to 41.2% patients in Germany/Poland, 50.8% in Spain, 55.2% in Belgium and 62% in Sweden.Laparoscopic surgery (conversion rate) was performed for cure in 5% (28%) of patients in Sweden, in 20.8% (20.6%) in Spain, in 28.6% (15.2%) in Belgium and in 14.5% (8.9%) in Germany/Poland.30 day mortality for anterior resection, abdominoperineal resection and Hartmann's procedure in Sweden, Belgium and Spain 2.0%, 2.3% and 3.1%, respectively. The German-Polish database reported an in-hospital mortality of 3.2%.
A European quality assurance project in rectal cancer is possible only after data collection is standardised.
2012. Vol. 14, no 8, 960-966 p.